FIA
CNTB

FNY Investment Advisers’s Connect Biopharma Holdings CNTB Stock Holding History

FNY Investment Advisers’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11K Hold
5,000
– – ﹤0.01% 601
2026
Q1 		$13K Buy
+5,000
New +$13K 0.01% 518

Other funds holding CNTB

KWM
Koa Wealth Management Encinitas, California $147M AUM 18.41% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

FNY Investment Advisers's CNTB Position: Q2 2026 in Review

FNY Investment Advisers held its Connect Biopharma Holdings (CNTB) position steady in Q2 2026 at 5,000 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #601.

FNY Investment Advisers first reported a position in CNTB in Q1 2026 and has held it in 2 quarters since. The position peaked at $13K in Q1 2026. 4 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • FNY Investment Advisers held 5,000 shares of Connect Biopharma Holdings worth $11K as of Q2 2026.
  • FNY Investment Advisers left its Connect Biopharma Holdings share count unchanged in Q2 2026.
  • Connect Biopharma Holdings made up ﹤0.01% of FNY Investment Advisers's portfolio in Q2 2026, its #601 holding.
  • FNY Investment Advisers first reported a position in Connect Biopharma Holdings in Q1 2026 and has held it in 2 quarters since.
  • FNY Investment Advisers's Connect Biopharma Holdings position peaked at $13K in Q1 2026.
  • 4 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.